Alpha 2.0
Login Register
» Articles » PMID: 20971590

Therapeutic Apheresis from the Early Civilizations to the Twenty-first Century

Overview
Journal Gastroenterol Clin Biol
Specialty Gastroenterology
Date 2010 Oct 26
PMID 20971590
Citations 4
Authors
A R Saniabadi
H Hanai
Affiliations
Soon will be listed here.
Citing Articles

Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.

Saniabadi A, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H World J Gastroenterol. 2014; 20(29):9699-715.

PMID: 25110409 PMC: 4123360. DOI: 10.3748/wjg.v20.i29.9699.

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.

Yokoyama Y, Kawai M, Fukunaga K, Kamikozuru K, Nagase K, Nogami K BMC Gastroenterol. 2013; 13:27.

PMID: 23399416 PMC: 3583683. DOI: 10.1186/1471-230X-13-27.

Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.

Leitner G, Worel N, Vogelsang H Transfus Med Hemother. 2012; 39(4):246-252.

PMID: 22969694 PMC: 3434328. DOI: 10.1159/000341801.

Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytes.

Yoshimura N, Tadami T, Kawaguchi T, Sako M, Yoshimoto H, Yamaka T J Gastroenterol. 2011; 47(1):49-55.

PMID: 21915624 DOI: 10.1007/s00535-011-0464-0.